ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Shares in Top Glove and other Malaysian glove manufacturers soared last year, spurred by global medical demand.   © AFP/Jiji
Market Spotlight

Malaysia stocks lag as glove makers lose grip on investors

COVID-19 resurgence and political turmoil dragging on market

P PREM KUMAR, Nikkei staff writer | Malaysia

KUALA LUMPUR -- Malaysia's stock market, which got a boost last year from companies that did well out of the coronavirus pandemic, is now a COVID-19 loser -- to the point where it stands out in 2021 as one of Asia's worst performing markets.

Last year, shares in the country's glove manufacturers rose exponentially as investors saw them capitalizing on soaring worldwide demand for medical gloves -- an essential part of the personal protective equipment used to combat the spread of the virus. Shares in Top Glove, Supermax and Hartalega, which together provide more than half the global supply of gloves, shot up by 170%, 1,233% and 147%, respectively, between May and December last year. They helped propel the benchmark index Kuala Lumpur Composite Index (KLCI), which rose 22% over the same period.

But the shine has come off the sector amid forced labor investigations involving some of the major glove makers in the country. Top Glove was slapped with an export ban in the U.S., while Supermax and Hartalega are under investigation by U.S. Customs & Border Protection.

In a reversal of last year's trend, shares of Top Glove, Supermax and Hartalega have declined 32%, 39% and 35%, year-to-date, respectively. Overall in 2021, the KLCI has declined almost 7%. That compares to growth of between 0.4% and 9.6% in Singapore, Japan and Thailand.

"It seems that the FBM KLCI is the only market that has not performed this year," Malaysia-based MIDF Amanah Investment Bank noted in a research report.

The bank listed several factors that have affected the bourse. They include a fourth wave of COVID-19 in the country, which led to a lockdown, and a mini "taper tantrum" after the U.S. Federal Reserve hinted at an interest rate hike in 2023.

Malaysia is also embroiled in political turbulence. Prime Minister Muhyiddin Yassin is trying to fend off attempts to unseat him, and is set to face the country's parliament on Monday after a seven-month hiatus amid the state of emergency in place since January. The reopening of parliament will increase the premier's vulnerability.

These factors have led to a persistent outflow of foreign investment. On a net basis foreign investors dumped Malaysian shares worth almost $1 billion in the first half of 2021, on top of an outflow of $4 billion in the first half of last year. During all of 2020 foreign investors sold Malaysia shares worth $6.2 billion on a net basis.

Bursa Malaysia CEO Muhamad Umar Swift told Nikkei that global "risk-off" sentiment, which has encouraged foreign investors to shift from equities into other asset classes, is also affecting other emerging markets in Southeast Asia.

"For example, as of the end of May 2021, Thailand and the Philippines have seen a cumulative net foreign outflow that is larger than [that of] Malaysia," he said. Foreign ownership of Malaysian equities remains above 20% of the market's capitalization, which Umar said was an indication that strategic and long-term investors remain.

Malaysia continues to battle COVID-19, with infections creeping back over 17,000 a day recently. As of July 25, the total caseload has crossed 1 million, with almost 8,000 fatalities.

Yeah Kim Leng, an economics professor at Sunway University, said the resurgence of COVID-19 and restrictions on movements imposed by the government will continue to dampen stocks this year. "The inability of the government to contain the pandemic, despite the declaration of an emergency and suspension of the parliament, has also heightened uncertainties over the country's recovery prospects," he said.

Muhyiddin has indicated the country will continue under lockdown, with only essential industries allowed to operate, until daily new cases come down to 4,000. To date, six states have been allowed to move to the second phase of the recovery plan, enabling a few more sectors to operate, though economically important Kuala Lumpur, Selangor and Johor are still in phase one.

"With corporate earnings expectations diminished by the weaker near-term economic outlook, it is not surprising that [Malaysia's] stock market performance has lagged the other ASEAN markets," said Yeah.

Longer-term, Bursa Malaysia's Umar believes a shift toward ethical or value-based investing globally augurs well for the exchange's Shariah-compliant trading. Currently, more than 75% of stocks on the exchange and 40% of exchange-traded funds are Shariah-compliant.

"The convergence of sustainability, responsible investing and Shariah investing is expected to deepen our competitive edge and make our offerings highly relevant to investors worldwide," he said.

Umar said Bursa Malaysia is looking to strengthen its global accessibility and broaden products and services in the derivatives market. The bourse has received a preliminary nod from the Securities Commission to conduct night trading sessions for derivatives in the fourth quarter. "This is a significant development that will provide greater access to global participants," he said.

Activity in the derivatives market has grown substantially since 2019. June's monthly trading volume for crude palm oil futures hit an all-time high of 1.7 million contracts, equivalent to 42.6 million tons of crude palm oil traded, surpassing the 1.66 million contracts traded in March 2020. Malaysia is the world's second-largest crude palm oil exporter, after Indonesia.

Vincent Lau, Rakuten Trade's head of equity sales, said stocks in Malaysia should perform better in the second half 2021 as vaccinations pick up steam and its economy and borders reopen.

Malaysia is vaccinating almost 400,000 people daily, and aims to increase it further this month -- in line with the government's aim to vaccinate 70% of the country's 32 million people by year's end.

MIDF noted that, given the headway in national inoculation efforts and a slew of fiscal programs, it expects an improvement in domestic demand with the reopening of the economy in the third and fourth quarters.

In line with the recovery, the bank also expects stronger interest in stocks in the automotive, banking, construction, consumer, health care, oil and gas, plantations, technology and industrial sectors. Industries that the bank is neutral on include gloves, power, telecommunications, and transportation and logistics.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more